Search Results

Expression of ERCC1 and class IIIβ tubulin for predicting effect of carboplatin/paclitaxel in patients with advanced inoperable non-small cell lung cancer

Authors: Ikeda, Satoshi; Takabe, Kazuhiko; Suzuki, Keiko

Source: Pathology International, Volume 59, Number 12, December 2009 , pp. 863-867(5)

Publisher: Blackwell Publishing

α-N-Heterocyclic Thiosemicarbazone Derivatives as Potential Antitumor Agents: A Structure-Activity Relationships Approach

Authors: Matesanz, Ana I.; Souza, Pilar

Source: Mini Reviews in Medicinal Chemistry, Volume 9, Number 12, October 2009 , pp. 1389-1396(8)

Publisher: Bentham Science Publishers

Development of histone deacetylase inhibitors as therapeutics for neurological disease

Authors: Gottesfeld, Joel M; Pandolfo, Massimo

Source: Future Neurology, Volume 4, Number 6, November 2009 , pp. 775-784(10)

Publisher: Future Medicine

DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets

Authors: Li, Long Shan; Morales, Julio C; Veigl, Martina; Sedwick, David; Greer, Sheldon; Meyers, Mark; Wagner, Mark; Fishel, Richard; Boothman, David A

Source: British Journal of Pharmacology, Volume 158, Number 3, October 2009 , pp. 679-692(14)

Publisher: Blackwell Publishing

3D-QSAR Studies on a Series of Inhibitors Docked into a New Homology Model of the DNA-PK Receptor

Authors: Cao, Ran; Zeng, Huahui; Zhang, Huabei

Source: Current Pharmaceutical Design, Volume 15, Number 32, November 2009 , pp. 3796-3825(30)

Publisher: Bentham Science Publishers

Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents

Authors: Takeshita, Takashi; Wu, Wenwen; Koike, Ayaka; Fukuda, Mamoru; Ohta, Tomohiko

Source: Cancer Chemotherapy and Pharmacology, Volume 64, Number 5, October 2009 , pp. 1039-1046(8)

Publisher: Springer

The Arabidopsis ATRIP ortholog is required for a programmed response to replication inhibitors

Authors: Sweeney, Paul R.; Britt, Anne B.; Culligan, Kevin M.

Source: The Plant Journal, Volume 60, Number 3, November 2009 , pp. 518-526(9)

Publisher: Blackwell Publishing

Robust methods for purification of histones from cultured mammalian cells with the preservation of their native modifications

Authors: Rodriguez-Collazo, Pedro; Leuba, Sanford H.; Zlatanova, Jordanka

Source: Nucleic Acids Research, Volume 37, Number 11, 20 June 2009 , pp. e81-e81(1)

Publisher: Oxford University Press

Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases

Author: Ardley, Helen C.

Source: Current Pharmaceutical Design, Volume 15, Number 31, November 2009 , pp. 3697-3715(19)

Publisher: Bentham Science Publishers

Hereditary ovarian cancer: biology, response to chemotherapy and prognosis

Author: Safra, Tamar

Source: Women's Health, Volume 5, Number 5, September 2009 , pp. 543-553(11)

Publisher: Future Medicine

Poly(ADP-Ribosylation): Beneficial Effects of Its Inhibition

Authors: Giansanti, V.; Dona, F.; Scovassi, A. I.

Source: Current Enzyme Inhibition, Volume 5, Number 2, July 2009 , pp. 99-109(11)

Publisher: Bentham Science Publishers

Ubiquitin-mediated control of oncogene and tumor suppressor gene products

Authors: Kitagawa, Kyoko; Kotake, Yojiro; Kitagawa, Masatoshi

Source: Cancer Science, Volume 100, Number 8, August 2009 , pp. 1374-1381(8)

Publisher: Blackwell Publishing

Radiosensitizing effects of gefitinib at different administration times in vitro

Authors: Zhuang, Hong-Qing; Sun, Jian; Yuan, Zhi-Yong; Wang, Jun; Zhao, Lu-Jun; Wang, Ping; Ren, Xiu-Bao; Wang, Chang-Li

Source: Cancer Science, Volume 100, Number 8, August 2009 , pp. 1520-1525(6)

Publisher: Blackwell Publishing

Fragile gene product, Fhit, in oxidative and replicative stress responses

Authors: Okumura, Hiroshi; Ishii, Hideshi; Pichiorri, Flavia; Croce, Carlo M.; Mori, Masaki; Huebner, Kay

Source: Cancer Science, Volume 100, Number 7, July 2009 , pp. 1145-1150(6)

Publisher: Blackwell Publishing

Small-molecule inhibitors of proteins involved in base excision repair potentiate the anti-tumorigenic effect of existing chemotherapeutics and irradiation

Authors: Reed, April M; Fishel, Melissa L; Kelley, Mark R

Source: Future Oncology, Volume 5, Number 5, June 2009 , pp. 713-726(14)

Publisher: Future Medicine

Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation

Author: Besson, Valerie C

Source: British Journal of Pharmacology, Volume 157, Number 5, July 2009 , pp. 695-704(10)

Publisher: Blackwell Publishing

Novel Targeted Radiosensitisers in Cancer Treatment

Authors: Zaidi, Shane H.; Huddart, Robert A.; Harrington, Kevin J.

Source: Current Drug Discovery Technologies, Volume 6, Number 2, June 2009 , pp. 103-134(32)

Publisher: Bentham Science Publishers

Tumor Hypoxia as a Modifier of DNA Strand Break and Cross-Link Repair

Authors: Chan, Norman; Koch, Cameron J.; Bristow, Robert G.

Source: Current Molecular Medicine, Volume 9, Number 4, May 2009 , pp. 401-410(10)

Publisher: Bentham Science Publishers

Accumulation of mitochondrial DNA damage and bioenergetic dysfunction in CSB defective cells

Authors: Osenbroch, Pia Ø.; Auk-Emblem, Pia; Halsne, Ruth; Strand, Janne; Forstrøm, Rune J.; van der Pluijm, Ingrid; Eide, Lars

Source: FEBS Journal, Volume 276, Number 10, May 2009 , pp. 2811-2821(11)

Publisher: Blackwell Publishing

The potential role and application of PARP inhibitors in cancer treatment

Author: Chalmers, Anthony J.

Source: British Medical Bulletin, Volume 89, Number 1, 28 March 2009 , pp. 23-40(18)

Publisher: Oxford University Press